메뉴 건너뛰기




Volumn 91, Issue 3, 2012, Pages 369-372

The right medicines-just not enough of them

(1)  Honig, P K a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABIRATERONE ACETATE; AFLIBERCEPT; AZILSARTAN MEDOXOMIL; BELIMUMAB; BOCEPREVIR; BRENTUXIMAB VEDOTIN; CAPTOPRIL; CLOBAZAM; CRIZOTINIB; DEFERIPRONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIDAXOMICIN; GABAPENTIN ENACARBIL; ICATIBANT; INDACATEROL; LINAGLIPTIN; ORPHAN DRUG; PREDNISONE; RETIGABINE; RILPIVIRINE; RIVAROXABAN; ROFLUMILAST; RUXOLITINIB; SPINOSAD; TELAPREVIR; TICAGRELOR; UNINDEXED DRUG; VANDETANIB; VEMURAFENIB; VILAZODONE;

EID: 84857215466     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.332     Document Type: Review
Times cited : (1)

References (7)
  • 1
    • 84857223541 scopus 로고    scopus 로고
    • Wrong questions, wrong answers? Are we getting the drugs we need? Clin
    • Lipworth, W.L., Kerridge, I.H. & Day, R .O. Wrong questions, wrong answers? Are we getting the drugs we need? Clin. Pharmacol. Ther. 91, 367-369 (2012).
    • (2012) Pharmacol. Ther. , vol.91 , pp. 367-369
    • Lipworth, W.L.1    Kerridge, I.H.2    Day, R.O.3
  • 2
    • 77149120426 scopus 로고    scopus 로고
    • The economics of drug development: A grim reality and a role for clinical pharmacology
    • Honig, P.K. & Lalonde, R. The economics of drug development: a grim reality and a role for clinical pharmacology. Clin. Pharmacol. Ther. 87, 247-251 (2010).
    • (2010) Clin. Pharmacol. Ther. , vol.87 , pp. 247-251
    • Honig, P.K.1    Lalonde, R.2
  • 3
    • 77149134011 scopus 로고    scopus 로고
    • Deconstructing the drug development enterprise: The new face of innovation
    • Kaitin, K. Deconstructing the drug development enterprise: the new face of innovation. Clin. Pharmacol. Ther. 87, 356-361 (2010).
    • (2010) Clin. Pharmacol. Ther. , vol.87 , pp. 356-361
    • Kaitin, K.1
  • 5
    • 84857237851 scopus 로고    scopus 로고
    • The Innovative Medicines Initiative: A European response to the innovation challenge
    • Goldman, M. The Innovative Medicines Initiative: a European response to the innovation challenge. Clin. Pharmacol. Ther. 91, 418-425 (2012).
    • (2012) Clin. Pharmacol. Ther. , vol.91 , pp. 418-425
    • Goldman, M.1
  • 7
    • 34447547659 scopus 로고    scopus 로고
    • Developments in postmarketing comparative effectiveness research
    • Schneeweis, S. Developments in postmarketing comparative effectiveness research. Clin. Pharmacol. Ther. 82, 143-156 (2007).
    • (2007) Clin. Pharmacol. Ther. , vol.82 , pp. 143-156
    • Schneeweis, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.